Start-Up Previews, December 2013
Executive Summary
This Month's Profile Group, The Conundrum Of Alzheimer’s Disease R&D, features profiles of Alzheon, Neurotrack Technologies, Rodin Therapeutics, and Tetra Discovery Partners. Plus these Start-Ups Across Health Care: Footfalls & Heartbeats, GrayBug, HIL Applied Medical, and neoSurgical.
You may also be interested in...
Neurotrack Technologies Inc.
With Alzheimer’s researchers now looking to head off the disease in its earlier stages, the hunt is on for ways to detect its presence when patients aren’t necessarily showing symptoms. Neurotrack Technologies Inc. is building a noninvasive eye-tracking test that it believes could replace the ADAS-COG battery of neurological tests that are the current front line of diagnosis of the disease.
neoSurgical Inc.
Closing trocar site incisions during abdominal laparoscopic surgery can be challenging for surgeons, as the small incisions and limited visualization make it difficult to place sutures and securely close the abdominal wall. If not closed properly, a weakness can be created in the abdominal wall that can lead to herniation and other complications. neoSurgical Inc.’s neoClose is a device solution designed to properly and securely close the trocar wound with two suture/anchor assemblies.
HIL Applied Medical Ltd.
HIL Applied Medical Ltd. is developing a lighter and more compact particle accelerator for proton therapy that has the potential to dramatically change the way cancer patients are currently being treated. The start-up claims its technology will significantly reduce the cost of building and equipping a proton therapy center to the level where practically any community hospital can afford one.